Literature DB >> 22762509

Patterns of physical activity in children with haemophilia.

C R Broderick1, R D Herbert, J Latimer, N van Doorn.   

Abstract

The current widespread use of prophylaxis in developed countries has enabled greater participation in physical activity. However, there are no data available on leisure-time physical activity in Australian children with haemophilia. The data reported here were obtained from a case-crossover study nested in a prospective cohort study of 104 boys with moderate and severe haemophilia followed for one year. Each child's physical activity was assessed using a modifiable physical activity questionnaire (Kriska's MAQ) administered at baseline, and a one-week prospective activity diary at a randomly determined time. Children were aged 4-18 years. The median time spent in sport or leisure-time physical activity in the preceding year was 7.9 h/week (IQR 4.6 to 12.9). The median time spent in vigorous physical activity was 3.8 h/week (IQR 1.6 to 6.4) and in moderate and vigorous physical activity 6.4 h/week (IQR 3.7 to 10.0). The median small-screen time was 2.5 h/day (IQR 0.5 to 2.5). Forty-five per cent of all children and 61% of children over the age of 10 years played at least one competitive sport. Averaged across one week, 43% of all children met the Australian government physical activity guidelines for children and 36% met the guidelines for small-screen time. This study provides the first data regarding leisure-time physical activity in children with haemophilia living in Australia. The majority of Australian children with haemophilia are not meeting the national physical activity and small-screen time guidelines.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22762509     DOI: 10.1111/j.1365-2516.2012.02904.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  11 in total

Review 1.  Telemedicine and telerehabilitation: current and forthcoming applications in haemophilia.

Authors:  Elena A Boccalandro; Giuseppe Dallari; Pier Mannuccio Mannucci
Journal:  Blood Transfus       Date:  2019-02-04       Impact factor: 3.443

2.  Deficits in physical function among young childhood cancer survivors.

Authors:  Megan C Hoffman; Daniel A Mulrooney; Julia Steinberger; Jill Lee; K Scott Baker; Kirsten K Ness
Journal:  J Clin Oncol       Date:  2013-06-24       Impact factor: 44.544

Review 3.  Recent advances in musculoskeletal physiotherapy for haemophilia.

Authors:  David Stephensen; Melanie Bladen; Paul McLaughlin
Journal:  Ther Adv Hematol       Date:  2018-07-02

Review 4.  Strategies to encourage physical activity in patients with hemophilia to improve quality of life.

Authors:  Miwa Goto; Hideyuki Takedani; Kazuhiko Yokota; Nobuhiko Haga
Journal:  J Blood Med       Date:  2016-05-17

5.  Evaluation of screen time activities and their relationship with physical activity, overweight and socioeconomic status in children 10-12 years of age in Sanandaj, Iran: A cross-sectional study in 2015.

Authors:  Ghobad Moradi; Farideh Mostafavi; Namamali Azadi; Nader Esmaeilnasab; Bijan Nouri
Journal:  Med J Islam Repub Iran       Date:  2016-11-26

6.  Using Oaxaca Decomposition to Study Socioeconomic Inequity of Physical Activity among Children Aged 10-12 Years: A Study in West of Iran.

Authors:  Farideh Mostafavi; Ghobad Moradi; Namamali Azadi; Nader Esmaeilnasab; Daem Roshani
Journal:  Int J Prev Med       Date:  2019-05-17

7.  Sports participation and physical activity in adult Dutch and Swedish patients with severe haemophilia: A comparison between intermediate- and high-dose prophylaxis.

Authors:  Olav Versloot; Erik Berntorp; Pia Petrini; Rolf Ljung; Jan Astermark; Margareta Holmström; Piet de Kleijn; Kathelijn Fischer
Journal:  Haemophilia       Date:  2019-01-28       Impact factor: 4.287

8.  Physical Activity Monitoring and Acceptance of a Commercial Activity Tracker in Adult Patients with Haemophilia.

Authors:  Juan J Carrasco; Sofía Pérez-Alenda; José Casaña; Emilio Soria-Olivas; Santiago Bonanad; Felipe Querol
Journal:  Int J Environ Res Public Health       Date:  2019-10-12       Impact factor: 3.390

9.  A multicentre, open-label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors.

Authors:  Midori Shima; Keiji Nogami; Sayaka Nagami; Seitaro Yoshida; Koichiro Yoneyama; Akira Ishiguro; Takashi Suzuki; Masashi Taki
Journal:  Haemophilia       Date:  2019-09-12       Impact factor: 4.287

10.  Movement behavior in hemophilia-from medicalized training approaches toward an active lifestyle.

Authors:  Johan Blokzijl; Merel A Timmer; Lize F D van Vulpen
Journal:  Res Pract Thromb Haemost       Date:  2021-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.